TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Translational Research Needs Coordination, Budget, Advisors Say. Former SWOG Chairman Hoogstraten Publishes Memoir. June 23, 2006